NTB Pharma

Immune Checkpoint Inhibitors

Health Tech & Life Sciences
Non Active, Sep 2017
Pre-Funding Jerusalem, Israel Founded 2016
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2016
Headcount
2
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

NTB Pharma seeks to develop novel targets for immuno-oncology and cancer immunotherapy utilizing the SLAM family receptors. NTB Pharma hypothesizes that SLAMF6, a highly potent agonistic receptor on immune cells, is a natural candidate for anti-melanoma immunotherapy. Its uniqueness may lie in a dual action on lymphocytes and myeloid-derived suppressor cells, augmenting T-cell function and reversing the deleterious effect of the tumor environment. NTB Pharma was established based on a technology developed in the laboratory of Prof. Lotem at Hadassah Medical Center, Jerusalem.

Q&A

What is NTB Pharma's primary focus?
NTB Pharma is focused on developing novel targets for immuno-oncology and cancer immunotherapy, specifically utilizing the SLAM family receptors.
What is NTB Pharma's proposed mechanism for anti-melanoma immunotherapy?
NTB Pharma hypothesizes that SLAMF6, an agonistic receptor on immune cells, can act dually on lymphocytes and myeloid-derived suppressor cells to augment T-cell function and reverse the deleterious effects of the tumor environment in anti-melanoma immunotherapy.
When was NTB Pharma founded?
NTB Pharma was founded in January 2016.
Where is NTB Pharma headquartered?
NTB Pharma is headquartered in Jerusalem, Israel, at 8 Sderot Churchill.
What is the current status of NTB Pharma?
NTB Pharma is currently inactive, a status it has held since September 2017.
How many employees does NTB Pharma have?
NTB Pharma has 1-10 employees.
Does NTB Pharma hold any patents?
Yes, NTB Pharma holds 1 patent.
Who is the CEO of NTB Pharma?
Gabi Frei is the CEO of NTB Pharma.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B

Highlights

1 Patents

Tags

biotechnologydiagnosticsregenerative-medicinemedical-technologiescancercancer-therapycell-therapy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2016-1
Employees (exact)2
Status reasonNon Active, Sep 2017